Search

Your search keyword '"Sakai, Yasunari"' showing total 573 results

Search Constraints

Start Over You searched for: Author "Sakai, Yasunari" Remove constraint Author: "Sakai, Yasunari"
573 results on '"Sakai, Yasunari"'

Search Results

3. Angiogenic and inflammatory responses in human induced microglia-like (iMG) cells from patients with Moyamoya disease

7. Clinical characteristics of SARS-CoV-2-associated encephalopathy in children: Nationwide epidemiological study

8. Progressive myoclonic epilepsy as an expanding phenotype of NGLY1-associated congenital deglycosylation disorder: A case report and review of the literature

13. Heterogeneity and mitochondrial vulnerability configurate the divergent immunoreactivity of human induced microglia-like cells

14. Shank3a/b isoforms regulate the susceptibility to seizures and thalamocortical development in the early postnatal period of mice

17. Acute liver failure worsened after respiratory syncytial virus infection in an infant with spinal muscular atrophy type I after receiving onasemnogene abeparvovec

19. Rapid and long‐lasting efficacy of high‐dose ambroxol therapy for neuronopathic Gaucher disease: A case report and literature review

22. High-Titer Anti-ZSCAN1 Antibodies in a Toddler Clinically Diagnosed with Apparent Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation Syndrome

23. Clinical characteristics of SARS-CoV-2-associated encephalopathy in children: Nationwide epidemiological study

25. Non‐conditioned cord blood transplantation for infection control in athymic CHARGE syndrome

26. Progressive myoclonic epilepsy as an expanding phenotype of NGLY1-associated congenital deglycosylation disorder: A case report and review of the literature

29. Clinical manifestations and epilepsy treatment in Japanese patients with pathogenic CDKL5 variants

35. Spliceosome malfunction causes neurodevelopmental disorders with overlapping features

36. TRPV4‐mediated Ca2+ deregulation causes mitochondrial dysfunction via the AKT/α‐synuclein pathway in dopaminergic neurons

37. Effects of melatonin on dopaminergic neuron development via IP3-mediated mitochondrial Ca2+ regulation in autism spectrum disorder

43. CD14 down‐modulation as a real‐time biomarker in Kawasaki disease.

44. TRPV4‐mediated Ca2+ deregulation causes mitochondrial dysfunction via the AKT/α‐synuclein pathway in dopaminergic neurons.

45. Angiogenic and inflammatory responses in human induced microglia-like (iMG) cells from patients with Moyamoya disease

50. Molecular diagnosis of 405 individuals with autism spectrum disorder

Catalog

Books, media, physical & digital resources